Etanercept is safely used for treating psoriatic arthritis in a patient complicated with type 1 hereditary angioedema

Noriko Umegaki, Masahiro Kira, Takahiko Horiuchi, Saori Itoi, Mamori Tani, Akinori Yokomi, Atsushi Tanemura, Hisaaki Miyahara, Michiyo Hatanaka, Hajime Kitamura, Etsuko Kitano, Ichiro Katayama

研究成果: Article査読

1 被引用数 (Scopus)

抄録

Hereditary angioedema (HAE) is a life-threatening disorder caused by deficiency or dysfunction of the C1 inhibitor protein. Patients with HAE are restricted in various medical treatments, which can induce an HAE attack. We herein report the first case of psoriatic arthritis (PSA) with type 1 HAE successfully treated with 25 mg of etanercept without HAE attack. Etanercept may represent a useful choice for treating patients with HAE accompanied by intractable PSA and rheumatoid arthritis (RA).

本文言語English
ページ(範囲)928-930
ページ数3
ジャーナルModern rheumatology
22
6
DOI
出版ステータスPublished - 2012 11
外部発表はい

ASJC Scopus subject areas

  • リウマチ学

フィンガープリント

「Etanercept is safely used for treating psoriatic arthritis in a patient complicated with type 1 hereditary angioedema」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル